William Rose - Net Worth and Insider Trading
William Rose Net Worth
The estimated net worth of William Rose is at least $186 Million dollars as of 2024-04-16. William Rose is the of Reata Pharmaceuticals Inc and owns about 1,079,768 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $186 Million. William Rose is also the Director of Impac Mortgage Holdings Inc and owns about 0 shares of Impac Mortgage Holdings Inc (IMPM) stock worth over $0. Details can be seen in William Rose's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Rose has not made any transactions after 2019-11-20 and currently still holds the listed stock(s).
Transaction Summary of William Rose
William Rose Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Rose owns 2 companies in total, including Reata Pharmaceuticals Inc () , and Impac Mortgage Holdings Inc () .
Click here to see the complete history of William Rose’s form 4 insider trades.
Insider Ownership Summary of William Rose
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Reata Pharmaceuticals Inc | 2019-11-20 | director & 10 percent owner & other: Member of a 10% owner group | |
| Impac Mortgage Holdings Inc | 2005-06-22 | director |
William Rose Latest Holdings Summary
William Rose currently owns a total of 2 stocks. Among these stocks, William Rose owns 1,079,768 shares of Reata Pharmaceuticals Inc (RETA) as of November 20, 2019, with a value of $186 Million and a weighting of 100%. William Rose also owns 0 shares of Impac Mortgage Holdings Inc (IMPM) as of June 22, 2005, with a value of $0 and a weighting of 0%.
Latest Holdings of William Rose
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2019-11-20 | 1,079,768 | 172.36 | 186,108,812 |
| IMPM | Impac Mortgage Holdings Inc | 2005-06-22 | 0 | 0.02 | 0 |
Holding Weightings of William Rose
William Rose Form 4 Trading Tracker
According to the SEC Form 4 filings, William Rose has made a total of 1 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 9,591 shares on November 20, 2019, which brought William Rose around $2 Million.
According to the SEC Form 4 filings, William Rose has made a total of 0 transactions in Impac Mortgage Holdings Inc (IMPM) over the past 5 years. The most-recent trade in Impac Mortgage Holdings Inc is the sale of 417 shares on June 22, 2005, which brought William Rose around $88,736.
Insider Trading History of William Rose
- 1
William Rose Trading Performance
GuruFocus tracks the stock performance after each of William Rose's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Rose is 32.73%. GuruFocus also compares William Rose's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Rose within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Rose's insider trading performs compared to the benchmark.
Performance of William Rose
Average Relative Return
104.9%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 39.79 | 32.73 | 75.45 | 104.9 | 57.63 | 81.44 |
| Relative Return to S&P 500(%) | 39.62 | 29.32 | 71.08 | 89.15 | 43.5 | 71.99 |
William Rose Ownership Network
Ownership Network List of William Rose
Ownership Network Relation of William Rose
William Rose Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
William Rose is the director & 10 percent owner & other: Member of a 10% owner group of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , EVP & Chief R&D Officer Rajiv Patni , and SVP & Chief Accounting Officer Bhaskar Anand .
Reata Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, William Rose made no insider transaction in Reata Pharmaceuticals Inc (). Other recent insider transactions involving Reata Pharmaceuticals Inc () include a net sale of 185,892 shares made by Manmeet Singh Soni , a net sale of 150,995 shares made by Dawn Carter Bir , and a net sale of 2,880 shares made by Bhaskar Anand .
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 530,967 shares of Reata Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 530,967 shares.
Reata Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
William Rose Mailing Address
Above is the net worth, insider trading, and ownership report for William Rose. You might contact William Rose via mailing address: 300 Crescent Court, Suite 700, Dallas Tx 75201.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
